Challenges in exploring the cytochrome P450 system as a source of variation in canine drug pharmacokinetics

Author： Martinez Marilyn N.   Antonovic Leposava   Court Michael   Dacasto Mauro   Fink-Gremmels Johanna   Kukanich Butch   Locuson Chuck   Mealey Katrina   Myers Michael J.   Trepanier Lauren  

Publisher： Informa Healthcare

ISSN： 0360-2532

Source： Drug Metabolism Reviews, Vol.45, Iss.2, 2013-05, pp. : 218-230

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Exploring the Relationship Between Expression of Cytochrome P450 Enzymes and Gefitinib Pharmacokinetics

By Swaisland Helen C.  

Clinical Pharmacokinetics, Vol. 45, Iss. 6, 2006-01 ,pp. : 633-644

Adis International

Access to resources Recommend Favorite

The role of cytochrome P450 in antiretroviral drug interactions

By Walubo Andrew  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 3, Iss. 4, 2007-08 ,pp. : 583-598

Informa Healthcare

Access to resources Recommend Favorite

Studying cytochrome P450 kinetics in drug metabolism

By Kramer Melissa A   Tracy Timothy S  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 4, Iss. 5, 2008-05 ,pp. : 591-603

Informa Healthcare

Access to resources Recommend Favorite

Cytochrome P450-mediated cardiovascular drug interactions

By Scheen André J  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 9, 2011-09 ,pp. : 1065-1082

Informa Healthcare

Access to resources Recommend Favorite

Tumour Cytochrome P450 and Drug Activation

By  

Current Pharmaceutical Design, Vol. 8, Iss. 15, 2002-07 ,pp. : 1335-1347

Bentham Science Publishers

Access to resources Recommend Favorite